Interview: Julia Brown – Portfolio Director Strategy and Sectors, Scottish Enterprise, UK

Heading the Life Sciences strategy for Scotland’s main economic development agency Scottish Enterprise, Julia Brown recalls some of the region’s unique features making it an ideal place for life Sciences investment: a historic focus on research and interest in clinical trials, great talent from world-class universities, as well as an ability to think outside of silos for better solutions in the healthcare of the future. In 2018, Scotland boasted a GBP 2.7bn pharmaceutical sector; what are the historical reasons that have made Scotland into such a great life sciences hub?
"For a life sciences company, there is the access to our outstanding universities and the quality of research within. Their sheer number has been key to attract pharmaceutical companies to come and look at non-clinical research collaborations and projects, but also clinical research collaborations in Scotland"
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report